Chemical Works of Gedeon Richter Plc (RGEDF)
40.70
-0.45
(-1.10%)
USD |
OTCM |
Nov 13, 16:00
Chemical Works of Gedeon Richter Price : 40.70 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 40.70 | 41.15 | 40.70 | 40.70 | 37.00 |
| Nov 12, 2026 | 40.75 | 41.16 | 40.75 | 41.16 | 26.00 |
| Nov 11, 2026 | 39.00 | 40.19 | 39.00 | 39.39 | 3203.00 |
| Nov 10, 2026 | 39.63 | 39.92 | 39.63 | 39.72 | 11153.00 |
| Nov 09, 2026 | 40.21 | 40.21 | 39.99 | 39.99 | 844.00 |
| Nov 06, 2026 | 39.72 | 39.72 | 39.50 | 39.50 | 96.00 |
| Nov 05, 2026 | 39.65 | 40.74 | 39.65 | 40.74 | 34.00 |
| Nov 04, 2026 | 40.98 | 40.98 | 40.98 | 40.98 | 20.00 |
| Nov 03, 2026 | 39.93 | 40.08 | 39.93 | 40.04 | 99.00 |
| Nov 02, 2026 | 40.34 | 40.39 | 39.78 | 40.36 | 31.00 |
| Oct 30, 2026 | 38.70 | 39.94 | 38.70 | 38.75 | 53.00 |
| Oct 29, 2026 | 39.82 | 40.96 | 39.18 | 40.96 | 852.00 |
| Oct 28, 2026 | 37.45 | 37.45 | 37.30 | 37.30 | 132.00 |
| Oct 27, 2026 | 41.06 | 41.06 | 41.04 | 41.04 | 28.00 |
| Oct 26, 2026 | 41.43 | 41.43 | 40.64 | 41.20 | 240.00 |
| Oct 23, 2026 | 39.61 | 40.58 | 39.61 | 40.44 | 184.00 |
| Oct 22, 2026 | 39.42 | 39.42 | 39.42 | 39.42 | 0.000 |
| Oct 21, 2026 | 39.42 | 39.42 | 39.42 | 39.42 | 6.000 |
| Oct 20, 2026 | 40.24 | 40.24 | 37.63 | 39.83 | 948.00 |
| Oct 19, 2026 | 39.59 | 39.63 | 39.59 | 39.63 | 7.000 |
| Oct 16, 2026 | 39.22 | 39.22 | 39.22 | 39.22 | 3.000 |
| Oct 15, 2026 | 40.12 | 40.26 | 37.45 | 38.63 | 1222.00 |
| Oct 14, 2026 | 38.93 | 38.93 | 37.99 | 37.99 | 15.00 |
| Oct 13, 2026 | 38.51 | 38.55 | 38.51 | 38.55 | 34.00 |
| Oct 12, 2026 | 37.26 | 38.37 | 37.26 | 38.37 | 119.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AstraZeneca PLC | 183.90 |
| ANI Pharmaceuticals, Inc. | 70.94 |
| Corcept Therapeutics, Inc. | 69.22 |
| Veru, Inc. | 2.07 |
| Avadel Pharmaceuticals Plc | 21.64 |
Price Related Metrics
| PE Ratio | 9.835 |
| PS Ratio | 2.530 |
| PEG Ratio | 0.4388 |
| Price to Book Value | 1.671 |
| Price to Free Cash Flow | 9.246 |
| Earnings Yield | 10.17% |
| Market Cap | 7.452B |
| PEGY Ratio | 0.3552 |
| Operating PE Ratio | 7.128 |
| Normalized PE Ratio | 9.835 |